BioCentury
ARTICLE | Company News

Connective Therapeutics, Xoma Corp. deal

June 13, 1994 7:00 AM UTC

The peptides are designed to elicit an immune response that selectively interferes with pathogenic T lymphocytes in autoimmune diseases. ...